AstraZeneca (AZN) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $262.31B | Exchange | NYSE |
| Sector | Healthcare | Industry | Drug Manufacturers - General |
| Country | GB | CEO | Pascal Claude Roland Soriot |
| IPO Date | 1993-05-12 | CAGR | 6.12% |
| Employees | 96,100 | Website | www.astrazeneca.com |
| Div. Yield | 6.84% | Payout Ratio | 46.98% |
| Buy Back Yield | 0.26% | Total Yield | 7.1% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| Enterprise Value | $304.11B | P/E Ratio | 18.28 |
| Forward P/E | 19.29 | PEG Ratio | 4.8 |
| P/S Ratio | 1.18 | P/B Ratio | 1.52 |
| P/CF Ratio | 5.03 | P/FCF Ratio | 8.15 |
| EPS | $9.26 | EPS Growth 1Y | 33.07% |
| EPS Growth 3Y | 119.87% | EPS Growth 5Y | 119.14% |
| Revenue Growth 1Y | 9.93% | Gross Margin | 0.8% |
| Operating Margin | 0.24% | Profit Margin | 0.17% |
| ROE | 0.22% | ROA | 0.09% |
| ROCE | 0.18% | Current Ratio | 0.91 |
| Quick Ratio | 0.71 | Cash Ratio | 0.23 |
| Debt/Equity | 0.72 | Interest Coverage | 8.54 |
| Altman Z Score | 3.4 | Piotroski Score | 8 |
AstraZeneca (AZN) valuation & financials
AstraZeneca (AZN) has a market capitalization of $262.31B and trades at a price-to-earnings ratio of 18.3. It operates in the Healthcare sector (Drug Manufacturers - General).
AstraZeneca's revenue grew +9.9% over the last year.
AstraZeneca's next earnings report is scheduled for July 27, 2026 before market open; analysts estimate EPS of $2.52.
AstraZeneca (AZN) — frequently asked questions
When does AstraZeneca (AZN) report earnings next?
AstraZeneca is expected to report earnings on July 27, 2026 before market open. Analysts estimate EPS of $2.52.
What is AstraZeneca's market cap?
AstraZeneca (AZN) has a market capitalization of $262.31B.
What is AZN's P/E ratio?
AstraZeneca trades at a price-to-earnings ratio of 18.3, with trailing twelve-month EPS of $9.26.
How fast is AstraZeneca growing?
AstraZeneca's revenue grew +9.9% over the last year.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)